Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer

Lisa Sanderson Cox, Jeff A Sloan, Christi Ann Patten, James A. Bonner, Susan M. Geyer, William L. McGinnis, Phillip J. Stella, Randolph Stuart Marks

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

There is limited research of smoking cessation following diagnosis of lung cancer. This prospective study assessed cigarette smoking behavior among 226 patients (142 males, 84 females) prior to, at the time of, and after the diagnosis of unresectable stage IIIA/IIIB non-small cell lung cancer and entry into a phase III trial examining combined thoracic radiation therapy and chemotherapy. Their mean ± S.D. Aage was 62.7 ± 9.4 years and 95.6% were Caucasian. Of 215 patients with a history of cigarette smoking, 69% (148/215) stopped smoking prior to entry in the trial, 9% (20/215) stopped smoking at some point during the course of the trial, 11% (24/215) continued smoking throughout the trial, 7% (16/215) were smoking at baseline but did not report subsequent smoking status, and smoking status at study entry was missing for the remaining patients. The majority of lung cancer patients were able to stop making. A notable subset of patients continued smoking despite diagnosis of lung cancer, enrollment in a clinical trial, treatment-related toxicity, and encouragement from clinicians to stop smoking. Smoking cessation interventions are needed for lung cancer patients who continue to smoke.

Original languageEnglish (US)
Pages (from-to)472-478
Number of pages7
JournalPsycho-Oncology
Volume11
Issue number6
DOIs
StatePublished - Nov 2002

Fingerprint

Non-Small Cell Lung Carcinoma
smoking
cancer
Smoking
Lung Neoplasms
Smoking Cessation
Smoke
Caucasian
Radiotherapy
Thorax
Clinical Trials
Prospective Studies
Drug Therapy
Research

ASJC Scopus subject areas

  • Oncology
  • Psychology(all)
  • Social Sciences (miscellaneous)

Cite this

Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. / Cox, Lisa Sanderson; Sloan, Jeff A; Patten, Christi Ann; Bonner, James A.; Geyer, Susan M.; McGinnis, William L.; Stella, Phillip J.; Marks, Randolph Stuart.

In: Psycho-Oncology, Vol. 11, No. 6, 11.2002, p. 472-478.

Research output: Contribution to journalArticle

Cox, Lisa Sanderson ; Sloan, Jeff A ; Patten, Christi Ann ; Bonner, James A. ; Geyer, Susan M. ; McGinnis, William L. ; Stella, Phillip J. ; Marks, Randolph Stuart. / Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. In: Psycho-Oncology. 2002 ; Vol. 11, No. 6. pp. 472-478.
@article{cdecdceb9aac4ea783a13fa5e05ed775,
title = "Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer",
abstract = "There is limited research of smoking cessation following diagnosis of lung cancer. This prospective study assessed cigarette smoking behavior among 226 patients (142 males, 84 females) prior to, at the time of, and after the diagnosis of unresectable stage IIIA/IIIB non-small cell lung cancer and entry into a phase III trial examining combined thoracic radiation therapy and chemotherapy. Their mean ± S.D. Aage was 62.7 ± 9.4 years and 95.6{\%} were Caucasian. Of 215 patients with a history of cigarette smoking, 69{\%} (148/215) stopped smoking prior to entry in the trial, 9{\%} (20/215) stopped smoking at some point during the course of the trial, 11{\%} (24/215) continued smoking throughout the trial, 7{\%} (16/215) were smoking at baseline but did not report subsequent smoking status, and smoking status at study entry was missing for the remaining patients. The majority of lung cancer patients were able to stop making. A notable subset of patients continued smoking despite diagnosis of lung cancer, enrollment in a clinical trial, treatment-related toxicity, and encouragement from clinicians to stop smoking. Smoking cessation interventions are needed for lung cancer patients who continue to smoke.",
author = "Cox, {Lisa Sanderson} and Sloan, {Jeff A} and Patten, {Christi Ann} and Bonner, {James A.} and Geyer, {Susan M.} and McGinnis, {William L.} and Stella, {Phillip J.} and Marks, {Randolph Stuart}",
year = "2002",
month = "11",
doi = "10.1002/pon.612",
language = "English (US)",
volume = "11",
pages = "472--478",
journal = "Psycho-Oncology",
issn = "1057-9249",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer

AU - Cox, Lisa Sanderson

AU - Sloan, Jeff A

AU - Patten, Christi Ann

AU - Bonner, James A.

AU - Geyer, Susan M.

AU - McGinnis, William L.

AU - Stella, Phillip J.

AU - Marks, Randolph Stuart

PY - 2002/11

Y1 - 2002/11

N2 - There is limited research of smoking cessation following diagnosis of lung cancer. This prospective study assessed cigarette smoking behavior among 226 patients (142 males, 84 females) prior to, at the time of, and after the diagnosis of unresectable stage IIIA/IIIB non-small cell lung cancer and entry into a phase III trial examining combined thoracic radiation therapy and chemotherapy. Their mean ± S.D. Aage was 62.7 ± 9.4 years and 95.6% were Caucasian. Of 215 patients with a history of cigarette smoking, 69% (148/215) stopped smoking prior to entry in the trial, 9% (20/215) stopped smoking at some point during the course of the trial, 11% (24/215) continued smoking throughout the trial, 7% (16/215) were smoking at baseline but did not report subsequent smoking status, and smoking status at study entry was missing for the remaining patients. The majority of lung cancer patients were able to stop making. A notable subset of patients continued smoking despite diagnosis of lung cancer, enrollment in a clinical trial, treatment-related toxicity, and encouragement from clinicians to stop smoking. Smoking cessation interventions are needed for lung cancer patients who continue to smoke.

AB - There is limited research of smoking cessation following diagnosis of lung cancer. This prospective study assessed cigarette smoking behavior among 226 patients (142 males, 84 females) prior to, at the time of, and after the diagnosis of unresectable stage IIIA/IIIB non-small cell lung cancer and entry into a phase III trial examining combined thoracic radiation therapy and chemotherapy. Their mean ± S.D. Aage was 62.7 ± 9.4 years and 95.6% were Caucasian. Of 215 patients with a history of cigarette smoking, 69% (148/215) stopped smoking prior to entry in the trial, 9% (20/215) stopped smoking at some point during the course of the trial, 11% (24/215) continued smoking throughout the trial, 7% (16/215) were smoking at baseline but did not report subsequent smoking status, and smoking status at study entry was missing for the remaining patients. The majority of lung cancer patients were able to stop making. A notable subset of patients continued smoking despite diagnosis of lung cancer, enrollment in a clinical trial, treatment-related toxicity, and encouragement from clinicians to stop smoking. Smoking cessation interventions are needed for lung cancer patients who continue to smoke.

UR - http://www.scopus.com/inward/record.url?scp=0036866829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036866829&partnerID=8YFLogxK

U2 - 10.1002/pon.612

DO - 10.1002/pon.612

M3 - Article

C2 - 12476429

AN - SCOPUS:0036866829

VL - 11

SP - 472

EP - 478

JO - Psycho-Oncology

JF - Psycho-Oncology

SN - 1057-9249

IS - 6

ER -